newdrugapprovals.org
FDA approves Praluent for the treatment of high LDL cholesterol
26 August 2015 Sanofi and Regeneron have announced that the US Food and Drug Administration (FDA) has approved Praluent® (alirocumab) Injection. Praluent is indicated as an adjunct to diet and maxi…